You need to enable JavaScript to run this app.
Study finds variation in evidence for FDA approval of novel psychiatric drugs
Regulatory News
Jeff Craven
Approval/marketing authorization
CDER
Clinical Trials
Pharmaceuticals
US Food and Drug Administration (FDA)